To our surprise, these Cyp7a1 transgenic mice were protected from high-fat and high-cholesterol diet–induced obesity, hepatic steatosis, and insulin resistance (Fig. 4A) (42). This evidence concerns the gene CYP7A1 and fatty liver disease.